Citation: Dw. Visscher et P. Tabaczka, Correspondence re: Jimenez RE, Wallis T, Tabasczka P, Visscher DW. Determination of Her-2/Neu status in breast carcinoma: Comparative analysis ofimmunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2000;13 : 37-45. In reply, MOD PATHOL, 14(3), 2001, pp. 263-263
Authors:
Visscher, DW
Nanjia-Makker, P
Heppner, G
Shekhar, PVM
Citation: Dw. Visscher et al., Tamoxifen suppresses histologic progression to atypia and DCIS in MCFIOAT xenografts, a model of early human breast cancer, BREAST CANC, 65(1), 2001, pp. 41-47
Citation: Re. Jimenez et al., Centrally necrotizing carcinomas of the breast - A distinct histologic subtype with aggressive clinical behavior, AM J SURG P, 25(3), 2001, pp. 331-337
Authors:
Jimenez, RE
Wallis, T
Tabasczka, P
Visscher, DW
Citation: Re. Jimenez et al., Determination of Her-2/neu status in breast carcinoma: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization, MOD PATHOL, 13(1), 2000, pp. 37-45
Authors:
Jimenez, RE
Bongers, S
Bouwman, D
Segel, M
Visscher, DW
Citation: Re. Jimenez et al., Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer, AM J SURG P, 24(1), 2000, pp. 123-128
Authors:
Mendelin, J
Grayson, M
Wallis, T
Visscher, DW
Citation: J. Mendelin et al., Analysis of chromosome aneuploidy in breast carcinoma progression by usingfluorescence in situ hybridization, LAB INV, 79(4), 1999, pp. 387-393
Authors:
Visscher, DW
Gingrich, DS
Leon-Armin, C
Tabaczka, P
Crissman, JD
Citation: Dw. Visscher et al., Histopathologic and flow-cytometric analysis of neoplastic and benign "background" tissue in breast carcinoma resections, ANAL CELL P, 17(3), 1998, pp. 167-175